Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Medico Remedies Financial Highlights
- Revenue: Medico Remedies reported revenue of ₹212.31 crore in FY26 vs ₹153.63 crore in FY25. It showed an increase of 38.20% on a yearly basis.
- Operating Profit: Medico Remedies reported an operating profit of ₹18.06 crore in FY26 vs ₹13.50 crore in FY25. It showed an increase of 33.78% on a year-on-year basis.
- Net Profit: Medico Remedies reported a net profit of ₹13.12 crore in FY26 vs ₹10.09 crore in FY25. It showed an increase of 30.03% on a yearly basis.
Medico Remedies Quarterly Result Highlights
- Medico Remedies reported revenue of ₹59.68 crore in Mar 2026, compared with ₹59.36 crore in Dec 2025, representing an increase of 0.54% on a quarter-on-quarter (QoQ) basis.
- Medico Remedies reported an operating profit of ₹8.32 crore in Mar 2026, compared with ₹3.83 crore in Dec 2025, representing an increase of 117.23% on a quarter-on-quarter (QoQ) basis.
- Medico Remedies reported a profit of ₹5.86 crore in Mar 2026, compared with ₹2.87 crore in Dec 2025, reflecting an increase of 104.18% on a QoQ basis.
- The earnings per share (EPS) of Medico Remedies stood at ₹1.22 during Mar 2026.